LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

Search

Ascendis Pharma A-S ADR

Open

Sector Healthcare

126.29 -4.51

Overview

Share price change

24h

Current

Min

125.75

Max

130.79

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+51.66 upside

Dividends

By Dow Jones

Next Earnings

5 Nov 2024

News Sentiment

By Acuity

50%

50%

190 / 389 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Ascendis Pharma A-S ADR Chart

Past performance is not a reliable indicator of future results.

Related News

12 Aug 2024, 13:03 UTC

Major Market Movers

Ascendis Pharma Shares Climb on U.S. FDA Approval for Hypoparathyroidism Treatment Yorvipath

Peer Comparison

Price change

Ascendis Pharma A-S ADR Forecast

Price Target

By TipRanks

51.66% upside

12 Months Forecast

Average 196.31 USD  51.66%

High 289 USD

Low 160 USD

Based on 13 Wall Street analysts offering 12 month price targets forAscendis Pharma A-S ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

12

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

127.69 / 130.31Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

190 / 389 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

$